Clinical Trial Update: Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity. [Phase 3]

View source ↗

Summary

A multinational Phase 3 trial assessing the pharmacokinetics of NRL972 and its relation to disease severity in liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• NRL972 (NRL972)

Snippet

Sponsor: Norgine | Conditions: Hepatic Cirrhosis | Phase 3 | Status: COMPLETED